Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

HOOKIPA Pharma Inc. - Common Stock (NQ:HOOK)

0.8403 UNCHANGED
Last Price Updated: 4:00 PM EDT, Aug 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about HOOKIPA Pharma Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
Why Is Brenmiller Energy (BNRG) Stock Up Today?
Brenmiller Energy stock is rising on Thursday as investors celebrate shares of BNRG regaining compliance with listing standards. 
Via InvestorPlace
Why Is Hookipa Pharma (HOOK) Stock Up 81% Today?
Hookipa Pharma stock is rising higher on Thursday as investors react to a purchase agreement for 15 million shares of HOOK. 
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
It's time to start off Thursday with a breakdown of the biggest pre-market stock movers worth keeping an eye on this morning! 
Via InvestorPlace
HOOKIPA Pharma Announces $21.25 Million Equity Investment from Gilead Sciences
From HOOKIPA Pharma Inc.
Via GlobeNewswire
Earnings Preview For HOOKIPA Pharma
 
Via Benzinga
Analyst Ratings for HOOKIPA Pharma
 
Via Benzinga
What 4 Analyst Ratings Have To Say About HOOKIPA Pharma
 
Via Benzinga
Recap: HOOKIPA Pharma Q1 Earnings
 
Via Benzinga
HOOKIPA Pharma Announces FDA Clearance of its Investigational New Drug Application for HB-500 for the Treatment of Human Immunodeficiency Virus
From HOOKIPA Pharma Inc.
Via GlobeNewswire
HOOKIPA Pharma Reports Third Quarter 2023 Financial Results and Recent Business Highlights
From HOOKIPA Pharma Inc.
Via GlobeNewswire
HOOKIPA Pharma Presents Positive Biomarker and Translational Data on HB-200 Monotherapy at Society for Immunotherapy of Cancer 2023
From HOOKIPA Pharma Inc.
Via GlobeNewswire
HOOKIPA Pharma to Report Third Quarter 2023 Financial Results and Recent Business Highlights on November 9, 2023
From HOOKIPA Pharma Inc.
Via GlobeNewswire
HOOKIPA Pharma Presents Additional Preliminary Phase 2 Data on HB-200 in Combination with Pembrolizumab as First-Line Treatment in Patients with HPV16+ Head and Neck Cancers at European Society for Medical Oncology Congress 2023
From HOOKIPA Pharma Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
 
Via Benzinga
HOOKIPA Pharma announces publication of preclinical data of hepatitis B virus (HBV) therapeutic vaccine developed in collaboration with Gilead Sciences
From HOOKIPA Pharma Inc.
Via GlobeNewswire
HOOKIPA Announces Executive Leadership Change
From HOOKIPA Pharma Inc.
Via GlobeNewswire
HOOKIPA Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
From HOOKIPA Pharma Inc.
Via GlobeNewswire
7 Biotech Stocks to Sell in September Before They Crash & Burn
These are just a few of the top biotech stocks to sell today - especially with each of the firms dealing with legitimate issues. 
Via InvestorPlace
HOOKIPA Pharma to participate in upcoming investor conferences in September
From HOOKIPA Pharma Inc.
Via GlobeNewswire
HOOKIPA Pharma Reports Second Quarter 2023 Financial Results and Recent Business Highlights
From HOOKIPA Pharma Inc.
Via GlobeNewswire
HOOKIPA Pharma to Report Second Quarter 2023 Financial Results and Recent Business Highlights on August 10, 2023
From HOOKIPA Pharma Inc.
Via GlobeNewswire
1847 Holdings And 3 Other Stocks Under $1 Insiders Are Buying
The Dow Jones closed higher by over 300 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
TeraWulf And 3 Other Stocks Under $3 Insiders Are Aggressively Buying
The Dow Jones closed lower by over 180 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested... 
Via Benzinga
CURO Group And 2 Other Stocks Under $3 Insiders Are Aggressively Buying
The Dow Jones closed lower by over 100 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
HOOKIPA Pharma And 3 Other Stocks Under $2 Insiders Are Aggressively Buying
The Dow Jones closed slightly higher on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
 
Via Benzinga
HOOKIPA Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
From HOOKIPA Pharma Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Intraday Session
 
Via Benzinga
HOOKIPA Pharma Announces Pricing of $50.0 Million Public Offering of Common Stock and Non-Voting Convertible Preferred Stock
From HOOKIPA Pharma Inc.
Via GlobeNewswire
HOOKIPA Pharma Announces Positive Preliminary Phase 2 Data on HB-200 in Combination with Pembrolizumab in Patients with HPV16+ Head and Neck Cancers
From HOOKIPA Pharma Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.